Novel Azaquinolones as PARP1 Inhibitors for Treating Cancer
- ACS Med Chem Lett. 2021 Mar 16;12(4):524-525. doi: 10.1021/acsmedchemlett.1c00122.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 33859786
DOI: 10.1021/acsmedchemlett.1c00122
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-